Showing results (591-600 of 605) with videos related to
Sort By:
Pageof 61
Eclinicalmedicine|May 4, 2026
Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trialLifan Zhang, Yujie He, Wenwen Wang, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 21, 2020
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical TrialJinmei Su, Mengtao Li, Lan He, et al.Clinical Rheumatology|October 28, 2021
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 studyJinmei Su, Mengtao Li, Lan He, et al.Annals of the Rheumatic Diseases|February 7, 2025
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.Annals of the Rheumatic Diseases|November 27, 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trialJinjing Liu, Ying Jiang, Shangzhu Zhang, et al.Annals of Translational Medicine|November 4, 2020
Development and formulation of the classification criteria for osteoarthritisCibo Huang, Zhiyi Zhang, Yaolong Chen, et al.Journal of Evidence-Based Medicine|December 18, 2025
Patient Version of Guideline for Fibromyalgia (2025 Edition)Zhiling Zhang, Pengxiang Zhou, Na He, et al.Annals of Translational Medicine|January 13, 2021
Erratum to development and formulation of the classification criteria for osteoarthritisCibo Huang, Zhiyi Zhang, Yaolong Chen, et al.JAMA Internal Medicine|June 2, 2025
Low-Dose Methotrexate for the Treatment of Inflammatory Knee Osteoarthritis: A Randomized Clinical TrialZhaohua Zhu, Qinghong Yu, Xiaomei Leng, et al.Annals of Translational Medicine|November 12, 2020
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)Zhiyi Zhang, Cibo Huang, Quan Jiang, et al.Pageof 61